Clifford Chance advises Luxinva on the voluntary public takeover offer of QIAGEN NV

Global law firm Clifford Chance is advising Luxinva S.A., a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA), as indirect co-investor alongside EQT XI Fund (“EQT Private Equity”) and CPP Investment Board Europe Inc., a wholly-owned subsidiary of CPP Investments, in connection with the intended voluntary public takeover offer for all registered ordinary shares in QIAGEN N.V. (“QIAGEN”).

QIAGEN and Crown NL Bidco BV, a holding company which is controlled by EQT Private Equity, have entered into a Business Combination Agreement regarding an all-cash public takeover offer for all outstanding shares in QIAGEN at an offer price of €46.50 per share, a premium of about 40.3% to the unaffected share price. The transaction values QIAGEN at approximately €10.8 billion in enterprise value (approximately US$12.1 billion at current exchange rates, including approximately US$1.1 billion of net debt).

The transaction is subject to certain conditions agreed in the Business Combination Agreement and to be set out in the Offer Document.

QIAGEN, headquartered in Venlo, Netherlands, is a scientific global leader specializing in technologies for molecular diagnostics, life-science tools, and bioinformatics. The company serves more than 500,000 customers worldwide across molecular diagnostics, applied testing, pharma, and academia.

The multijurisdictional Clifford Chance core team consisted of partners Thomas Krecek (Frankfurt), Christian Vogel (Düsseldorf), Dominik Heß (Düsseldorf), Samuel Frommelt (Munich; all Corporate/M&A), Bruce Embley (Private Equity, London) and Lynn Ammar (Corporate/M&A, Abu Dhabi) as well as senior associates Lennart Göbel (Corporate/M&A, Düsseldorf), Mhairi Cruickshank, Cari Sweeney (both Corporate, Dubai), and Marie Möllering (Corporate, Frankfurt), as well as associates Olga Filmanovic (Private Equity, London), Marie Burckhardt and Mona Fuchs (both Corporate, Munich).

Amsterdam-based partners Jan-Hendrik Horsmeier (Corporate) and Ernst van der Touw (Private Equity) and senior associate Femke Buijs (Corporate) advised on Dutch law aspects.

Partners Dimitri Slobodenjuk (Düsseldorf) and Philipp Girardet (London), senior associate Hendrik Kühn and associate Patricia Trapp (both Düsseldorf) advised on antitrust matters. The tax team comprised partners Richard Kalaher (London), Dominik Engl (Frankfurt) and Michiel Sunderman (Amsterdam) as well as associates Paul Harrington, Alfie Futerman and Angel Chun (all London), Alec Sanderson (Amsterdam) and Tali Lee (New York). Partner Axel Wittmann (Frankfurt), partner Stefanie Ferring and associate Thiébaud Lohisse (both Luxembourg) provided additional support in connection with certain capital markets and transactional aspects.

Press contact: Nadja Fersch